RestorixHealth Marks Hyperbaric Awareness Month with Nationwide Celebration
RestorixHealth, a leading provider of wound care and hyperbaric center management services across the United States, has announced its participation in recognizing Hyperbaric Awareness Month this May. The annual observance, launched in 2021 by the Undersea and Hyperbaric Medical Society in collaboration with Hyperbaric Awareness USA, is dedicated to raising awareness about the clinical benefits and applications of hyperbaric oxygen therapy (HBO2). Over the years, the initiative has grown into a nationwide effort, bringing together healthcare providers, researchers, and industry stakeholders to highlight advancements in the field of hyperbaric medicine.
Hyperbaric oxygen therapy, commonly referred to as HBO2 therapy, is a specialized medical treatment designed to enhance the body’s natural healing processes. During a session, patients breathe 100% oxygen while inside a pressurized chamber. The pressure within this chamber is typically increased to approximately two to three times that of normal atmospheric pressure. This elevated pressure enables oxygen to dissolve more effectively into the bloodstream, allowing it to reach tissues that may otherwise have limited oxygen supply due to injury or disease.
The increased oxygen delivery achieved through HBO2 therapy plays a critical role in tissue repair and regeneration. By improving oxygenation at the cellular level, the therapy supports wound healing, reduces inflammation, and promotes the formation of new blood vessels. Additionally, HBO2 therapy has been shown to enhance the body’s ability to fight certain types of infections, including those affecting bone and deep tissue structures. These benefits make it a valuable treatment option for patients with chronic, non-healing wounds and other complex medical conditions.
Despite being considered an advanced therapeutic modality in modern medicine, hyperbaric oxygen therapy is far from new. According to Dan Christopher, Vice President of HBO2 Training & Education and Corporate Safety Director at RestorixHealth, the treatment has been in use for more than a century. Its early applications can be traced back to naval medicine, where it was used to treat decompression sickness in divers. Over time, the therapy has evolved and expanded into a wide range of clinical applications, supported by growing scientific evidence and technological advancements.
Christopher emphasized that while HBO2 therapy is often viewed as cutting-edge, it is fundamentally a safe and well-established treatment when used appropriately. He noted that its long history of use, combined with ongoing research and improved clinical protocols, has reinforced its role as a reliable option for enhancing healing in carefully selected patients.
RestorixHealth plays a significant role in expanding access to hyperbaric medicine through its extensive network of partners. The company collaborates with nearly 300 healthcare organizations across 41 states, and more than half of these partner sites offer HBO2 therapy as part of their comprehensive wound care services. These facilities vary in size and capability, ranging from centers equipped with monoplace chambers—designed to treat a single patient at a time—to those housing larger multiplace chambers capable of accommodating multiple patients simultaneously.
Within these centers, patient care is guided by rigorous clinical protocols to ensure safety and effectiveness. Before undergoing HBO2 therapy, patients receive thorough evaluations and assessments to determine whether the treatment is appropriate for their specific condition. This careful screening process is essential, as HBO2 therapy is typically reserved for conditions that have demonstrated clinical benefit from enhanced oxygen delivery.
Christopher highlighted RestorixHealth’s commitment to maintaining the highest standards of safety across all its managed centers. This includes not only ensuring proper patient selection but also providing comprehensive training for healthcare teams, implementing strict operational guidelines, and adhering to approved clinical indications. By prioritizing safety and quality, the company aims to deliver consistent, evidence-based care to patients who may benefit from this advanced therapy.
Dr. William H. Tettelbach, Chief Medical Officer at RestorixHealth, underscored the broader significance of Hyperbaric Awareness Month in advancing the company’s mission. He explained that one of the organization’s primary goals is to increase access to effective treatments for patients with non-healing wounds, whether external or internal. For many of these patients, HBO2 therapy can be a transformative intervention, offering improved healing outcomes and, in some cases, preventing more invasive procedures.
Dr. Tettelbach noted that raising awareness about hyperbaric oxygen therapy is essential not only for healthcare providers but also for patients and communities. By educating stakeholders about the therapy’s benefits, indications, and safety profile, initiatives like Hyperbaric Awareness Month help ensure that more individuals can access appropriate care in a timely manner. He emphasized that increased awareness can lead to earlier referrals, better treatment outcomes, and a broader understanding of how advanced therapies can be integrated into standard medical practice.
The observance of Hyperbaric Awareness Month also reflects the ongoing evolution of hyperbaric medicine as a field. As research continues to uncover new applications and refine existing protocols, the role of HBO2 therapy in modern healthcare is expected to expand. From chronic wound management to infection control and beyond, the therapy offers a unique approach to addressing complex medical challenges through enhanced oxygen delivery.
In conclusion, RestorixHealth’s participation in Hyperbaric Awareness Month highlights its dedication to advancing patient care through education, innovation, and collaboration. By supporting initiatives that promote understanding of hyperbaric oxygen therapy, the company is helping to bridge gaps in awareness and access, ultimately improving outcomes for patients with challenging medical conditions. As the healthcare community continues to explore the full potential of HBO2 therapy, efforts to educate and inform will remain a critical component of its success.
About RestorixHealth
Committed to excellence in wound care, RestorixHealth is the wound care solutions company providing programs, services, products and education across the care continuum. From developing and operating wound centers in partnership with hospitals, through delivering professional wound care in nursing facilities and in-home settings, to supporting patients through the coordination of wound supplies, RestorixHealth’s solutions increase access to care, reduce hospital admissions and most importantly, improve patient outcomes and quality of life. For more information, visit www.RestorixHealth.com.
